X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11212) 11212
Book Chapter (64) 64
Publication (20) 20
Dissertation (17) 17
Book / eBook (11) 11
Web Resource (3) 3
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7646) 7646
oncology (6233) 6233
metastatic colorectal-cancer (4261) 4261
female (3666) 3666
cancer (3547) 3547
male (3182) 3182
chemotherapy (3169) 3169
middle aged (2840) 2840
aged (2696) 2696
metastasis (2303) 2303
colorectal cancer (2153) 2153
adult (2137) 2137
metastatic colorectal cancer (1717) 1717
animals (1593) 1593
care and treatment (1587) 1587
tumors (1531) 1531
treatment outcome (1482) 1482
bevacizumab (1455) 1455
antineoplastic combined chemotherapy protocols - therapeutic use (1399) 1399
survival (1344) 1344
prognosis (1286) 1286
fluorouracil (1271) 1271
research (1251) 1251
pharmacology & pharmacy (1249) 1249
colorectal neoplasms - drug therapy (1207) 1207
metastatic breast-cancer (1196) 1196
colorectal neoplasms - pathology (1148) 1148
medicine & public health (1125) 1125
1st-line treatment (1095) 1095
antineoplastic agents - therapeutic use (1095) 1095
aged, 80 and over (1085) 1085
cell lung-cancer (1079) 1079
oxaliplatin (1079) 1079
neoplasms - drug therapy (1063) 1063
metastatic melanoma (1062) 1062
cetuximab (1061) 1061
therapy (1033) 1033
surgery (1004) 1004
neoplasm metastasis (986) 986
analysis (979) 979
irinotecan (955) 955
leucovorin (934) 934
cancer therapies (909) 909
mutation (908) 908
health aspects (895) 895
breast-cancer (872) 872
immunotherapy (868) 868
patients (858) 858
colorectal-cancer (856) 856
disease-free survival (798) 798
metastases (786) 786
fluorouracil - administration & dosage (773) 773
clinical trials (755) 755
breast cancer (744) 744
camptothecin - analogs & derivatives (714) 714
neoplasm staging (704) 704
drug therapy (703) 703
carcinoma (698) 698
capecitabine (692) 692
melanoma (686) 686
review (663) 663
antineoplastic combined chemotherapy protocols - adverse effects (661) 661
expression (649) 649
mice (649) 649
cell line, tumor (642) 642
trial (641) 641
5-fluorouracil (638) 638
retrospective studies (635) 635
phase-iii trial (624) 624
phase-ii (622) 622
angiogenesis (618) 618
endothelial growth-factor (618) 618
phase-ii trial (616) 616
cancer research (609) 609
biomarkers (604) 604
cell biology (584) 584
medicine, research & experimental (581) 581
genetic aspects (574) 574
antibodies, monoclonal - therapeutic use (567) 567
hematology, oncology and palliative medicine (562) 562
growth-factor receptor (557) 557
survival analysis (554) 554
open-label (535) 535
antineoplastic agents (533) 533
survival rate (520) 520
development and progression (518) 518
neoplasms - therapy (514) 514
liver neoplasms - secondary (512) 512
lung-cancer (507) 507
immunology (504) 504
combination (502) 502
antineoplastic agents - pharmacology (500) 500
antimitotic agents (498) 498
medical prognosis (495) 495
clinical trials as topic (493) 493
colorectal neoplasms - genetics (491) 491
toxicity (491) 491
neoplasms - pathology (489) 489
deoxycytidine - analogs & derivatives (487) 487
randomized-trial (483) 483
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11006) 11006
French (161) 161
German (106) 106
Japanese (76) 76
Russian (43) 43
Spanish (25) 25
Italian (12) 12
Polish (8) 8
Czech (5) 5
Korean (5) 5
Portuguese (5) 5
Turkish (4) 4
Chinese (3) 3
Hungarian (3) 3
Arabic (2) 2
Norwegian (2) 2
Slovenian (2) 2
Icelandic (1) 1
Latvian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 2015, Volume 21, Issue 43, pp. 12234 - 12248
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2018, Volume 88, pp. 77 - 86
The FIRE-3 trial investigated combination chemotherapy plus either cetuximab or bevacizumab in patients with untreated metastatic colorectal cancer (mCRC... 
Conversion therapy | Resection | Cetuximab | Surgery | Metastatic colorectal cancer | Bevacizumab | SURVIVAL | HEPATECTOMY | OPEN-LABEL | LIVER METASTASES | EXPERT CONSENSUS STATEMENT | DISEASE | PHASE-3 TRIAL | THERAPIES | ONCOLOGY | Antimitotic agents | Care and treatment | Chemotherapy | Analysis | Colorectal cancer | Metastasis | Diagnosis | Antineoplastic agents | Cancer
Journal Article